Lysyl Oxidase Promotes Actin-Dependent Neutrophil Activation and Cytotoxicity Toward Retinal Endothelial Cells in Diabetes
Diabetes · 2026
DOI: 10.2337/db25-0541 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, 2026. Verfasst von Mahesh Agarwal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of California, Los Angeles, Los Angeles, CA. Hauptthemen laut MEDLINE: Protein-Lysine 6-Oxidase, Endothelial Cells, Neutrophil Activation, Actins. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: AOU NIH HHS, NEI NIH HHS, Gavin Herbert Eye Institute at the University of California, Irvine..
Themen: Diabetes mellitus
Abstract (Originalsprache)
Activated neutrophils contribute to retinal endothelial cell (EC) death and capillary degeneration associated with early diabetic retinopathy (DR), a major vision-threatening complication of diabetes. However, the factors and mechanisms driving neutrophil activation and cytotoxicity in diabetes remain insufficiently understood. Here, we show that lysyl oxidase (LOX), a matrix cross-linking and stiffening enzyme that increases retinal EC susceptibility to activated neutrophils, simultaneously activates neutrophils in its soluble form. Specifically, treatment of diabetic mice with LOX inhibitor β-aminopropionitrile (BAPN) prevented the diabetes-induced increase in neutrophil activation (extracellular release of neutrophil elastase and superoxide) and cytotoxicity toward cocultured mouse retinal ECs. Mouse neutrophils and differentiated (neutrophil-like) human HL-60 cells treated with recombinant LOX alone exhibited significant activation and cytotoxicity. Mechanistically, this LOX-induced neutrophil activation was associated with biphasic F-actin remodeling, with the initial and rapid (∼10 min) F-actin depolymerization followed by a significant increase in F-actin polymerization and polarization. Preventing the initial F-actin depolymerization blocked LOX-induced neutrophil activation and cytotoxicity toward cocultured retinal ECs. Finally, this biphasic F-actin remodeling was found to be essential for LOX-induced membrane aggregation of azurophilic granule marker CD63 and NADPH organizer p47phox, which are associated with extracellular release of neutrophil elastase and superoxide, respectively. By revealing a previously unrecognized causal link between LOX and actin-dependent neutrophil activation in diabetes, these findings provide fresh mechanistic insights into the proinflammatory role of LOX in early DR that goes beyond its canonical matrix-stiffening effects. Article Highlights Activated neutrophils kill retinal endothelial cells (ECs) in early diabetic retinopathy, but how neutrophils become activated in diabetes is not well understood. We found that lysyl oxidase (LOX), whose matrix-localized form activates retinal ECs, can also directly activate neutrophils in its soluble form. LOX-induced release of neutrophil elastase and superoxide is mediated by actin remodeling and membrane aggregation of azurophilic granules. The dual ability of LOX to activate neutrophils (in its soluble form) and retinal ECs (in its matrix-localized form) implicates it as a key proinflammatory target for early diabetic retinopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, University of California, Los Angeles, Los Angeles, CA.
- Doheny Eye Institute, Pasadena, CA.
- Molecular, Cellular, and Integrative Physiology Interdepartmental PhD Program, University of California, Los Angeles, Los Angeles, CA.
- Department of Ophthalmology, Center for Translational Vision Research, University of California, Irvine, Irvine, CA.
- Gavin Herbert Eye Institute, University of California, Irvine, Irvine, CA.
ORCID-Profile: Mahesh Agarwal, Sathishkumar Chandrakumar, Emma M Lessieur, Kaustabh Ghosh
Förderung
- AOU NIH HHS
- NEI NIH HHS
- Gavin Herbert Eye Institute at the University of California, Irvine.
- W. M. Keck Foundation
- Department of Ophthalmology at the University of California, Los Angeles
- National Eye Institute core grant to Center for Translational Vision Research at the University of California, Irvine
- All of Us Research Program
Zitieren
APA
Agarwal, M., Chandrakumar, S., Santiago Tierno, I., Lessieur, E. M., Bollinger, Z. R., Kern, T. S., & Ghosh, K. (2026). Lysyl Oxidase Promotes Actin-Dependent Neutrophil Activation and Cytotoxicity Toward Retinal Endothelial Cells in Diabetes. Diabetes. https://doi.org/10.2337/db25-0541
Vancouver
Agarwal M, Chandrakumar S, Santiago Tierno I, Lessieur EM, Bollinger ZR, Kern TS, et al. Lysyl Oxidase Promotes Actin-Dependent Neutrophil Activation and Cytotoxicity Toward Retinal Endothelial Cells in Diabetes. Diabetes. 2026. doi:10.2337/db25-0541
BibTeX
@article{Agarwal2026,
author = {Agarwal, Mahesh and Chandrakumar, Sathishkumar and Santiago Tierno, Irene and Lessieur, Emma M and Bollinger, Zak R and Kern, Timothy S and Ghosh, Kaustabh},
title = {Lysyl Oxidase Promotes Actin-Dependent Neutrophil Activation and Cytotoxicity Toward Retinal Endothelial Cells in Diabetes},
journal = {Diabetes},
year = {2026},
doi = {10.2337/db25-0541}
}
EUVIMED